Premium
Fatal outcome in a liver transplant recipient with COVID‐19
Author(s) -
Huang JiaoFeng,
Zheng Kenneth I.,
George Jacob,
Gao HaiNv,
Wei RuNan,
Yan HuaDong,
Zheng MingHua
Publication year - 2020
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/ajt.15909
Subject(s) - medicine , context (archaeology) , liver transplantation , disease , covid-19 , intensive care medicine , hepatocellular carcinoma , liver disease , respiratory failure , transplantation , infectious disease (medical specialty) , biology , paleontology
Liver injury is common in patients with COVID‐19, but little is known about its clinical presentation and severity in the context of liver transplant. We describe a case of COVID‐19 in a patient who underwent transplant 3 years ago for hepatocellular carcinoma. The patient came to clinic with symptoms of respiratory disease; pharyngeal swabs for severe acute respiratory syndrome coronavirus 2 were positive. His disease progressed rapidly from mild to critical illness and was complicated by several nosocomial infections and multiorgan failure. Despite multiple invasive procedures and rescue therapies, he died from the disease. The management of COVID‐19 in the posttransplant setting presents complex challenges, emphasizing the importance of strict prevention strategies.